Lower level of low-density lipoprotein cholesterol by statin prevents progression of coronary restenosis after successful stenting in acute myocardial infarction

Internal Medicine

Volumn 45, Issue 15, 2006, Pages 885-890

  Iwata, Atsushi ^a   Miura, Shin Ichiro ^a   Shirai, Kazuyuki ^a   Kawamura, Akira ^a   Tomita, Sayo ^a   Matsuo, Yoshino ^a   Zhang, Bo ^a   Nishikawa, Hiroaki ^a   Kumagai, Koichiro ^a   Matsuo, Kunihiro ^a   Saku, Keijiro ^a  

^a FUKUOKA UNIVERSITY HOSPITAL   (Japan)

Author keywords

Adhesion molecules; Chemokines; Coronary stenosis; Lipoprotein cholesterol; Low density; Statin

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; ATORVASTATIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; C REACTIVE PROTEIN; CALCIUM CHANNEL BLOCKING AGENT; CELL ADHESION MOLECULE; CHEMOKINE; CHEMOKINE RECEPTOR; DIURETIC AGENT; GLYCERYL TRINITRATE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NICORANDIL; PRAVASTATIN; TICLOPIDINE;

ACUTE HEART INFARCTION; ADULT; ANGIOCARDIOGRAPHY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY STENT; CORRELATION ANALYSIS; DISEASE COURSE; FEMALE; FOLLOW UP; HUMAN; MALE; PLEIOTROPY; QUANTITATIVE DIAGNOSIS; REGRESSION ANALYSIS; RESTENOSIS;

AGED; CHEMOKINES; CHOLESTEROL, LDL; CORONARY ARTERY BYPASS; CORONARY RESTENOSIS; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; STENTS;

EID: 33748295625     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.45.1757     Document Type: Article

References (24)

1. Serruys PW, de Feyter P, Macaya C, et al. Lescol Intervention Prevention Study (LIPS) Investigators. Fluvastatin for prevention of cardiac events following successful first percutaneous coronary intervention: a randomized controlled trial. JAMA 287: 3215-3222, 2002.
2. LaRosa JC, Grundy SM, Waters DD, et al. Treating to New Targets (TNT) Investigators. Intensive lipid lowering with atorvastatin in patients with stable coronary disease. N Engl J Med 352: 1425-1435, 2005.
3. Nissen SE, Tuzcu EM, Schoenhagen P, et al. Reversal of Atherosclerosis with Aggressive Lipid Lowering (REVERSAL) Investigators. Statin therapy, LDL cholesterol, C-reactive protein, and coronary artery disease. N Engl J Med 352: 29-38, 2005.
4. Walter DH, Fichtlscherer S, Britten MB, et al. Statin therapy, inflammation and recurrent coronary events in patients following coronary stent implantation. J Am Coll Cardiol 38: 2006-2012, 2001.
5. Makuuchi H, Furuse A, Endo M, et al. Effect of pravastatin on progression of coronary atherosclerosis in patients after coronary artery bypass surgery. Circ J 69: 636-643, 2005.
6. Jang Y, Lincoff AM, Plow EF, Topol EJ. Cell adhesion molecules in coronary artery disease. J Am Coll Cardiol 24: 1591-1601, 1994.
7. Yip HK, Hung WC, et al. Serial changes in circulating concentrations of soluble CD40 ligand and C-reactive protein in patients with unstable angina undergoing coronary stenting. Role of inflammatory mediators in predicting late restenosis. Circ J 69: 890-895, 2005.
8. Takemoto M, Liao JK. Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors. Arterioscler Thromb Vasc Biol 21: 1712-1719, 2001.
9. Kawamura A, Miura S, Murayama T, et al. Changes in the expression of leukocyte adhesion molecules throughout the acute phase of myocardial infarction. J Atheroscler Thromb 11: 29-34, 2004.
10. Ronnemaa T, Viikari J, Irjala K, Peltola O. Marked decrease in serum HDL cholesterol level during acute myocardial infarction. Acta Med Scand 207: 161-166, 1980.
11. Chan AW, Bhatt DL, Chew DP, et al. Early and sustained survival benefit associated with statin therapy at the time of percutaneous coronary intervention. Circulation 105: 691-696, 2002.
12. Shirai K, Lansky AJ, Mintz GS, et al. Comparison of the angiographic outcomes after beta versus gamma vascular brachytherapy for treatment of in-stent restenosis. Am J Cardiol 92: 1409-1413, 2003.
13. Goy JJ, Stauffer JC, Siegenthaler M, Benoit A, Seydoux C. A prospective randomized comparison between paclitaxel and sirolimus stents in the real world of interventional cardiology: the TAXi trial. J Am Coll Cardiol 45: 308-311, 2005.
14. Blankenberg S, Rupprecht HJ, Bickel C, et al. Circulating cell adhesion molecules and death in patients with coronary artery disease. Circulation 104: 1336-1342, 2001.
15. Kawamura A, Miura S, Murayama T, et al. Increased expression of monocyte CD11a and ICAM-1 in patients with initial atherosclerotic coronary stenosis. Circ J 68: 6-10, 2004.
16. Kawamura A, Miura S, Fujino M, et al. CXCR3 chemokine receptor - plasma IP10 interaction in patients with coronary artery disease. Circ J 67: 851-854, 2003.
17. Rezaie-Majd A, Prager GW, Bucek RA, et al. Simvastatin reduces the expression of adhesion molecules in circulating monocytes from hypercholesterolemic patients. Arterioscler Thromb Vasc Biol 23: 397-403, 2003.
18. Rezaie-Majd A, Maca T, Bucek RA, et al. Simvastatin reduces expression of cytokines interleukin-6, interleukin-8, and monocyte chemoattractant protein-1 in circulating monocytes from hypercholesterolemic patients. Arterioscler Thromb Vasc Biol 22: 1194-1199, 2002.
19. Waehre T, Damas JK, Gullestad L, et al. Hydroxymethylglutaryl coenzyme a reductase inhibitors down-regulate chemokines and chemokine receptors in patients with coronary artery disease. J Am Coll Cardiol 41: 1460-1467, 2003.
20. Yuan Y, Verna LK, Wang NP, et al. Cholesterol enrichment upregulates intercellular adhesion molecule-1 in human vascular endothelial cells. Biochim Biophys Acta 1534: 139-148, 2001.
21. Walter DH, Fichtlscherer S, Britten MB, et al. Statin therapy, inflammation and recurrent coronary events in patients following coronary stent implantation. J Am Coll Cardiol 38: 2006-2012, 2001.
22. Ridker PM, Cannon CP, Morrow D, et al. Pravastatin or atorvastatin evaluation and infection therapy-thrombolysis in myocardial infarction 22 (PROVE IT-TIMI 22) investigators. C-reactive protein levels and outcomes after statin therapy. N Eng J Med 352: 20-28, 2005.
23. Hattori Y, Nakanishi N, Kasai K. Statin enhances cytokine-mediated induction of nitric oxide synthesis in vascular smooth muscle cells. Cardiovasc Res 54: 649-658, 2002.
24. Nawawi H, Osman NS, Yusoff K, Khalid BA. Reduction in serum levels of adhesion molecules, interleukin-6 and C-reactive protein following short-term low-dose atorvastatin treatment in patients with non-familial hypercholesterolemia. Horm Metab Res 35: 479-485, 2003.